Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Kasturba Medical College, |
RCV001250923 | SCV001167673 | likely pathogenic | Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome | 2020-02-03 | criteria provided, single submitter | clinical testing | The variant is considered to be likely pathogenic as it qualifies following criteria of ACMG: PM1, PM2, PP2,PP3 and PP4 |
Labcorp Genetics |
RCV001860606 | SCV002312603 | uncertain significance | not provided | 2021-08-02 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 818216). This sequence change replaces aspartic acid with asparagine at codon 437 of the COMP protein (p.Asp437Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with COMP-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). |
Department of Clinical Genetics, |
RCV002226751 | SCV002505725 | likely pathogenic | Multiple epiphyseal dysplasia type 1 | 2021-08-01 | criteria provided, single submitter | clinical testing |